Case Report: SAPHO Syndrome Mimicking Bone Metastases During Treatment With Pembrolizumab for Non-small Cell Lung Cancer gan Yuko Kubo, Kimiteru Ito, Yutaka Fujiwara, Tatsuya Yoshida, Masahiko Kusumoto

Cael y testun llawn

Successful IMRT and concurrent chemotherapy for a patient with intrathoracic extensive‐stage small cell lung cancer gan Yoshitsugu Horio, Hiroyuki Tachibana, Junichi Shimizu, Waki Hosoda, Yutaka Fujiwara

Cael y testun llawn

Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis gan Teppei Yamaguchi, Junichi Shimizu, Reiko Matsuzawa, Naohiro Watanabe, Yoshitsugu Horio, Yutaka Fujiwara

Cael y testun llawn

The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report gan Kazushi Yoshida, Yutaka Fujiwara, Yasushi Goto, Takashi Kohno, Akihiko Yoshida, Koji Tsuta, Yuichiro Ohe

Cael y testun llawn

Effects of aprepitant on the pharmacokinetics of controlled-release oral oxycodone in cancer patients. gan Yutaka Fujiwara, Masanori Toyoda, Naoko Chayahara, Naomi Kiyota, Takanobu Shimada, Yoshinori Imamura, Toru Mukohara, Hironobu Minami

Cael y testun llawn

Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report gan Yutaka Fujiwara, Katsuhiro Masago, Reiko Matsuzawa, Teppei Yamaguchi, Naohiro Watanabe, Junichi Shimizu, Eiichi Sasaki, Yoshitsugu Horio

Cael y testun llawn

The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-s... gan Yutaka Fujiwara, Kazuhiro Shimomura, Kazuhiro Shimomura, Teppei Yamaguchi, Junichi Shimizu, Naohiro Watanabe, Reiko Matsuzawa, Kenta Murotani, Kenta Murotani, Yoshitsugu Horio

Cael y testun llawn

Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors gan Yutaka Fujiwara, Hirotsugu Kenmotsu, Noboru Yamamoto, Toshio Shimizu, Kan Yonemori, Christopher Ocampo, Apurvasena Parikh, Sumiko Okubo, Kazuteru Fukasawa, Haruyasu Murakami

Cael y testun llawn

Mixed response to osimertinib and the beneficial effects of additional local therapy gan Yuki Shinno, Yasushi Goto, Jun Sato, Ryo Morita, Yuji Matsumoto, Shuji Murakami, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe

Cael y testun llawn

Metabolomics evaluation of serum markers for cachexia and their intra-day variation in patients with advanced pancreatic cancer. gan Yutaka Fujiwara, Takashi Kobayashi, Naoko Chayahara, Yoshinori Imamura, Masanori Toyoda, Naomi Kiyota, Toru Mukohara, Shin Nishiumi, Takeshi Azuma, Masaru Yoshida, Hironobu Minami

Cael y testun llawn

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure gan Takaaki Mizuno, Hidehito Horinouchi, Sho Watanabe, Jun Sato, Ryo Morita, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe

Cael y testun llawn

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer gan Ryota Shibaki, Shuji Murakami, Yuki Shinno, Yuji Matsumoto, Yasushi Goto, Shintaro Kanda, Hidehito Horinouchi, Yutaka Fujiwara, Noriko Motoi, Noboru Yamamoto, Yuichiro Ohe

Cael y testun llawn

Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101). gan Yutaka Fujiwara, Shogo Kobayashi, Hiroaki Nagano, Masashi Kanai, Etsuo Hatano, Masanori Toyoda, Tetsuo Ajiki, Yuki Takashima, Kenichi Yoshimura, Akinobu Hamada, Hironobu Minami, Tatsuya Ioka

Cael y testun llawn

FIGHT‐102: A phase 1 study of pemigatinib in Japanese patients with advanced malignancies gan Yutaka Fujiwara, Yasutoshi Kuboki, Masayuki Furukawa, Nobumasa Mizuno, Hiroki Hara, Tatsuya Ioka, Makoto Ueno, Yasuo Takahashi, Shunji Takahashi, Shinji Takeuchi, Christine Lihou, Tao Ji, Chenwei Tian, Toshio Shimizu

Cael y testun llawn

Left atrial extension of metastatic lung tumor via pulmonary vein: report on the first case of Ewing sarcoma gan Hironobu Minami, Kazuhiko Nakagawa, Soichi Fumita, Tomoo Ito, Shigeo Hara, Yutaka Okita, Kenji Okada, Takanori Oka, Tomonori Shirasaka, Naomi Kiyota, Yutaka Fujiwara, Naoko Chayahara, Hideo Tomioka, Tomoko Kataoka, Toru Mukohara, Yohei Funakoshi

Cael y testun llawn

Evaluating Clinical Genome Sequence Analysis by Watson for Genomics gan Kota Itahashi, Shunsuke Kondo, Shunsuke Kondo, Takashi Kubo, Yutaka Fujiwara, Mamoru Kato, Hitoshi Ichikawa, Hitoshi Ichikawa, Takahiko Koyama, Reitaro Tokumasu, Jia Xu, Claudia S. Huettner, Vanessa V. Michelini, Laxmi Parida, Takashi Kohno, Takashi Kohno, Noboru Yamamoto

Cael y testun llawn

Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma gan Yusuke Okuma, Yasushi Goto, Fumiyoshi Ohyanagi, Kuniko Sunami, Yoshiro Nakahara, Satoru Kitazono, Keita Kudo, Yuichi Tambo, Shintaro Kanda, Noriko Yanagitani, Atsushi Horiike, Hidehito Horinouchi, Yutaka Fujiwara, Hiroshi Nokihara, Noboru Yamamoto, Makoto Nishio, Yuichiro Ohe, Yukio Hosomi

Cael y testun llawn

Efficacy of Taletrectinib (AB-106/DS-6051b) in ROS1+ NSCLC: An Updated Pooled Analysis of U.S. and Japan Phase 1 Studies gan Sai-Hong Ignatius Ou, MD, PhD, Yutaka Fujiwara, MD, PhD, Alice T. Shaw, MD, PhD, Noboru Yamamoto, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Frank Fan, MD, Yuki Hao, MSc, Yanfei Gao, MSc, Pasi A. Jänne, MD, Takashi Seto, MD

Cael y testun llawn